Cargando…

Impact of Subinhibitory Concentrations of Metronidazole on Morphology, Motility, Biofilm Formation and Colonization of Clostridioides difficile

Clostridioides difficile infection (CDI) is the primary cause of health-care-associated infectious diarrhea. Treatment requires mostly specific antibiotics such as metronidazole (MTZ), vancomycin or fidaxomicin. However, approximately 20% of treated patients experience recurrences. Treatment with MT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doan, Tri-Hanh-Dung, Bernet-Camard, Marie-Françoise, Hoÿs, Sandra, Janoir, Claire, Péchiné, Séverine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137534/ https://www.ncbi.nlm.nih.gov/pubmed/35625268 http://dx.doi.org/10.3390/antibiotics11050624

Ejemplares similares

Impact of subinhibitory concentrations of metronidazole on proteome of Clostridioides difficile strains with different levels of susceptibility
por: Doan, Tri-Hanh-Dung, et al.
Publicado: (2020)

The Effect of Subinhibitory Concentration of Metronidazole on the Growth and Biofilm Formation on Toxigenic Clostridioides difficile Strains Belonging to Different Ribotypes
por: Wultańska, Dorota, et al.
Publicado: (2023)

Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile
por: Bruxelle, Jean-François, et al.
Publicado: (2017)

Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection
por: Péchiné, Séverine, et al.
Publicado: (2018)

Biofilm Structures in a Mono-Associated Mouse Model of Clostridium difficile Infection
por: Soavelomandroso, Anna P., et al.
Publicado: (2017)

Immunization Using GroEL Decreases Clostridium difficile Intestinal Colonization
por: Péchiné, Séverine, et al.
Publicado: (2013)

Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen Clostridioides difficile
por: Bradshaw, William J., et al.
Publicado: (2019)

Plasmid-mediated metronidazole resistance in Clostridioides difficile
por: Boekhoud, Ilse M., et al.
Publicado: (2020)

Characterization of Non-Toxigenic Clostridioides difficile Strains Isolated from Preterm Neonates and In Vivo Study of Their Protective Effect
por: Couturier, Jeanne, et al.
Publicado: (2020)

Sequence-Based Identification of Metronidazole-Resistant Clostridioides difficile Isolates
por: Smits, Wiep Klaas, et al.
Publicado: (2022)

Subinhibitory Concentrations of Biogenic Silver Nanoparticles Affect Motility and Biofilm Formation in Pseudomonas aeruginosa
por: Saeki, Erika Kushikawa, et al.
Publicado: (2021)

Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile
por: Boekhoud, Ilse M, et al.
Publicado: (2021)

Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection
por: Gonzales-Luna, Anne J, et al.
Publicado: (2021)

Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water
por: Cizek, Alois, et al.
Publicado: (2022)

The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile
por: Wultańska, Dorota, et al.
Publicado: (2020)

Clostridioides difficile minimal nutrient requirements for flagellar motility
por: Schwanbeck, Julian, et al.
Publicado: (2023)

710. Increased Clinical Failure Rates Associated with Reduced Metronidazole Susceptibility in Clostridioides difficile
por: Gonzales-Luna, Anne, et al.
Publicado: (2018)

840. Clinical Failure Rates Associated with Hemin-induced Metronidazole Resistance in Clostridioides difficile
por: Gonzales-Luna, Anne J, et al.
Publicado: (2019)

Which is the Preferred Regimen for Non-Severe Clostridioides difficile Infection in Korea, Vancomycin or Metronidazole?
por: Kim, Jieun, et al.
Publicado: (2022)

Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition
por: Lacotte, Pierre-Alexandre, et al.
Publicado: (2022)

Polysaccharide II Surface Anchoring, the Achilles’ Heel of Clostridioides difficile
por: Malet-Villemagne, Jeanne, et al.
Publicado: (2023)

Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole
por: de Freitas, Michele C. R., et al.
Publicado: (2016)

Effect of sub-MIC values of metronidazole, ciprofloxacin, and imipenem on the growth and toxin production in Clostridioides difficile
por: Shayegan Mehr, Farahnaz Sadat, et al.
Publicado: (2019)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection
por: Zhang, Kevin, et al.
Publicado: (2021)

Subinhibitory Concentrations of Allicin Decrease Uropathogenic Escherichia coli (UPEC) Biofilm Formation, Adhesion Ability, and Swimming Motility
por: Yang, Xiaolong, et al.
Publicado: (2016)

Phase variation of a signal transduction system controls Clostridioides difficile colony morphology, motility, and virulence
por: Garrett, Elizabeth M., et al.
Publicado: (2019)

Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis
por: Kansau, Imad, et al.
Publicado: (2016)

Clostridioides difficile biofilms: A mechanism of persistence in the gut?
por: Frost, Lucy R., et al.
Publicado: (2021)

Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
por: Rahmoun, Layan Abu, et al.
Publicado: (2021)

2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients
por: Vega, Ana D, et al.
Publicado: (2019)

Metronidazole for Treatment of Clostridioides difficile Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality
por: Alves, Joana Darc Freitas, et al.
Publicado: (2022)

Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection
por: Whitney, Laura, et al.
Publicado: (2023)

Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
por: Olaitan, Abiola O., et al.
Publicado: (2023)

Ethanol at Subinhibitory Concentrations Enhances Biofilm Formation in Salmonella Enteritidis
por: He, Shoukui, et al.
Publicado: (2022)

Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence
por: Taggart, Megan G., et al.
Publicado: (2021)

Review of the Impact of Biofilm Formation on Recurrent Clostridioides difficile Infection
por: Rubio-Mendoza, Daira, et al.
Publicado: (2023)

Vancomycin vs metronidazole use for the treatment of Clostridioides difficile infection in a tertiary care hospital in Saudi Arabia
por: Alhameed, Abrar F., et al.
Publicado: (2023)

RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility
por: Edwards, Adrianne N., et al.
Publicado: (2019)

Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections
por: Yin, Jianyi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_odt84liqq5pm8cokm6qeogmg17